Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now


Accentus Medical Announces Completion of Management Buyout

Accentus Medical, a global leader in clinically established implant surfaces, has announced today the successful completion of a management buyout. The buyout was delivered through a combination of investment from the incumbent management team, and a spectrum of private investors with knowledge and expertise in the implantable medical device market and advanced materials sector. The buyout transaction eliminates historic debt and provides the company with fresh equity investment to take forward the business plan.

The company continues to make good progress in commercialising Agluna®, an innovative surface technology that harnesses the anti-microbial properties of silver ions in preventing device related infection, and in international growth of its Acusure® plasma spray coatings for implant fixation.

Brian Howlett, Board Chairman, said “I am delighted by the success of the buyout led by the executive management team, and to have the opportunity to chair the company board under the new ownership structure. I look forward to supporting the management in furthering the very positive progress that they have made in building a strong commercial platform, and to help secure value growth for the new investors.”

Philip Agg, Chief Executive Officer, said “I am looking forward to reinforcing and exploiting our position as a globally recognised leader in clinically established implant surfaces. The new ownership structure provides the company with an excellent network of investors with a passion for, and track record in, building strong, successful businesses in our target markets and technology sector.”


For further information, please contact:
Philip Agg, CEO
T: +44 (0)1235 434328